Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 41, Issue 2, 1996, Pages 87-90

  Santolaya Forgas, Joaquin ^a   Jessup, Joanna ^b   Burd, Laurence I ^b   Prins, Gail S ^b   Burton, Barbara K ^b  

^a MICHAEL REESE HOSPITAL   (United States)

^b NONE

Author keywords

estriol; pregnancy outcome; pregnancy trimester, second

Indexed keywords

ALPHA FETOPROTEIN; ESTRIOL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTRIOL BLOOD LEVEL; FEMALE; FETUS; FETUS OUTCOME; FETUS WASTAGE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN; ESTRIOL; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RISK; RISK FACTORS;

EID: 0030038884     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Tulchinsky D: The value of estrogens in the high risk pregnancy. In Management of the High Risk Pregnancy. Edited by WN Spellacy. Baltimore, University Park Press, 1976, pp 29-47
2. Greene JW Jr: Estriols. In Management of High-Risk Pregnancy. Edited by JT Queenan. Oradell, New Jersey, Medical Economics Company Book Division, 1980, pp 95-121
3. Ryan KJ: Placental synthesis of steroid hormones. In Maternal-Fetal Endocrinology. Edited by D Tulchinsky, KJ Ryan. Philadelphia, WB Saunders, 1980, pp 3-16
4. Wald NJ, Cuckle HS, Densem JW, et al: Maternal serum screening for Down's syndrome in early pregnancy. Br Med J 1988;297:883-887
5. Haddow JE, Palomaki GE, Knight GJ, et al: Prenatal screening for Down's syndrome with the use of maternal serum markers. N Engl J Med 1992;327.588-593
6. Phillips OP, Elias S, Shulman LP, et al: Maternal serum screening for fetal Down's syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: A prospective 2-year study. Obstet Gynecol 1992;80:353-358
7. Burton BK, Prins GS, Verp MS: A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. Am J Obstet Gynecol 1993;169-526-530
8. Burton BK: Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alphafetoprotein. Obstet Gynecol 1988;72:709-713
9. Davis RO, Goldberg RL, Boots L, et al: Elevated levels of midtruimester maternal serum alpha fetoprotem are associated with preterm delivery but not with fetal growth retardation. Am J Obstet Gynecol 1992;67:596-601
10. Gonen R, Perez R, David M, et al: The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol 1992;80:83-86
11. Gravett CP, Buckmaster JG, Watson PT, et al: Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome. Am J Med Genet 1992;44:485-486
12. Tanaka M, Natori M, Khono H, et al: Fetal growth in patients with elevated maternal serum hCG levels. Obstet Gynecol 1993;1:341-343
13. Murphy K, Cox M, Coulter K, et al: Unexplained elevated second trimester maternal serum hCG is not associated with adverse pregnancy outcome (abstr). Am J Obstet Gynecol 1993;168:338
14. Roberts JM: Pregnancy-related hypertension. In MaternalFetal Medicine: Principles and Practice. Second edition. Edited by RK Creasy, R Resnik. Philadelphia, WB Saunders, 1989, pp 777-824
15. Hollingsworth DR, Moore TR: Diabetes and Pregnancy. In Maternal-Fetal Medicine: Principles and Practice. Second edition. Edited by RK Creasy, R Resnik. Philadelphia, WB Saunders, 1989, pp 925-989